Biogen tops profit estimates as cost cuts take hold, Alzheimer’s drug Leqembi launch picks up

[ad_1] A test tube is seen in front of displayed Biogen logo in this illustration taken…

These health-care companies see opportunity ahead from Alzheimer’s drug approval

[ad_1] As patients with Alzheimer’s disease seek out a newly approved treatment, they will need MRIs,…

Medicare will pay for Alzheimer’s drug Leqembi. What patients and doctors should know

[ad_1] The Alzheimer’s drug Leqembi is seen in this undated handout image obtained by Reuters on…

FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage

[ad_1] The Food and Drug Administration on Thursday fully approved the Alzheimer’s treatment Leqembi, a pivotal…

Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024

[ad_1] Jay Reinstein, who suffers from Alzheimer’s, receives an injection so he can have a PET…